Anesthetic Efficacy of PECS II Block and Parasternal Block

Anesthetic Efficacy of PECS II Block and Parasternal Block for Quadrantectomy With or Without Axillary Dissection

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03016117

Enrollment

Registered

2017-01-10

Start date

2017-03-15

Completion date

2018-11-29

Last updated

2019-01-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anesthesia, Local

Brief summary

The study evaluate the anesthetic efficacy of Pecs II block II and parasternal block during quadrantectomy with or without axillary dissection, in breast cancer surgery

Detailed description

All patients receive Pecs II block and parasternal block, under ultrasound guidance. Pecs II block, performed at the 4th rib level, and parasternal block performed at the level of the 2nd and 4th intercostal space level. Data on the anesthesia, side effects and pain, will be recorded

Interventions

PROCEDUREPecs II block and parasternal block

The Pecs II block will be performed under ultrasound guidance, at fourth rib level, on the axillary line, into the fascial plane between pectoralis minor muscle and serratus muscle. The parasternal block will be performed under ultrasound guidance, at the second and fourth intercostal space, between the pectoralis major muscle and the intercostal muscles, near to the external intercostal membrane.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 75 Years

Healthy volunteers

Inclusion criteria

* patients who need of quadrantectomy with or without axillary dissection * ASA I-III patients * age between 18 and 75 years * filled informed consent

Exclusion criteria

* pregnant women * obesity (BMI \> 39,99) * radical mastectomy * ASA IV patients * chest wall abnormalities * neurological disorders * septic status * chest skin infections * coagulopathies

Design outcomes

Primary

Measure	Time frame	Description
Anesthetic efficacy	The anesthetic efficacy was assessed in the first 72 hours, after block	The anesthetic efficacy is tested by cold and touch test

Secondary

Measure	Time frame	Description
Painkillers request	The painkillers request was assessed in the first 72 hours, after surgery	mg of morphine
Side effects	The side effects recorded in the first 72 hours, after surgery	Nausea, vomiting, local anesthetic systemic toxicity

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026